Graphical Abstract Highlights d DSB repair via TA-HRR prevents gene alterations caused by aberrant NHEJ d DNA-RNA hybrid-dependent recruitment of Rad52 is the key step to initiate TA-HRR d R-loop processing by Rad52 and XPG is critical for the initiation of TA-HRR d Rad52 recruits BRCA1 to antagonize the RIF1-53BP1 complex during TA-HRR SUMMARY Given that genomic DNA exerts its function by being transcribed, it is critical for the maintenance of homeostasis that DNA damage, such as double-strand breaks (DSBs), within transcriptionally active regions undergoes accurate repair. However, it remains unclear how this is achieved.
In Brief
Human Rad52 and R-loop facilitate highfidelity DNA repair in actively transcribed regions.
INTRODUCTION
Double-strand breaks (DSBs) are a deleterious form of DNA damage, which are predominantly repaired by one of two pathways: non-homologous end joining (NHEJ) or homologous recombination repair (HRR). The mechanism by which cells make a choice between these two repair pathways for DSB repair has been extensively studied (Chapman et al., 2012) . Current evidence suggests that the activity of nucleases, such as MRE11, EXO1, and BLM/DNA2, to initiate and progress DSB end resection is a critical determinant of the pathway choice (Shibata et al., 2014) . More recently, it has been suggested that the repair pathway choice is not simply regulated by cell cycle phase; indeed, NHEJ-promoting factors, such as Ku70/80, DNA-PKcs, and 53BP1, are rapidly recruited and suppress HRR at most DSBs even in S/G2 phase (Chanut et al., 2016; Isono et al., 2017; Shibata et al., 2011) . Chromatin status is another major factor influencing the choice (Beucher et al., 2009; Lemaître and Soutoglou, 2014) . Recent evidence from genome-wide approaches suggests that HRR factors are preferentially accumulated at DSBs in transcriptionally active regions (Marnef et al., 2017) . However, the molecular mechanism by which HRR is chosen as a predominant pathway for DSB repair in transcriptionally active regions remains unclear.
At transcriptionally active regions, transcribed RNAs are enriched around the chromatin, which can influence a range of cellular processes, including DNA repair. The roles of RNAs in DSB repair have been extensively studied. It has been shown that transcription is inhibited by DNA damage signaling in order to facilitate DSB repair (Kruhlak et al., 2007; Pankotai et al., 2012; Shanbhag et al., 2010) . In addition, R-loop, a three-stranded structure of nucleic acids consisting of a DNA-RNA hybrid and displaced single-stranded DNA (ssDNA), has been shown to negatively regulate genome stability (Aguilera and García-Muse, 2012) . In contrast, a positive role of RNAs in genome maintenance has emerged in a recent study showing their function in HRR with both formation and resolution of DNA-RNA hybrids contributing to efficient HRR in S. pombe (Ohle et al., 2016) . Another example of the positive contribution of RNAs to DNA repair is shown in S. cerevisiae where transcribed RNAs nearby DSBs can serve as a template for repair, in which Rad52, a central player of HRR in yeast, promotes the use of RNAs via its biochemical activity for promoting DNA-RNA hybrid formation (Keskin et al., 2014; Mazina et al., 2017) . However, although human Rad52 possesses the same biochemical activity in vitro, Figure 1 . Transcription Directs the DSB Repair Pathway toward HRR (A) The effect of DRB (100 mM) treatment for 1 hr on total RNA synthesis was measured by 5-ethynyl uridine (EU) incorporation. Cells in S/G2 phase were identified by positive CENPF staining. Representative images and quantification of the EU signal intensity are shown. In each cell, the position of nucleus and nucleoli were whether and how Rad52 contributes to DSB repair in human cells is unknown.
In this study, we reveal a process representing transcriptionassociated DSB repair via HR and sought to elucidate the underlying molecular mechanisms for this repair pathway. Our detailed pathway analysis revealed that active transcription, combined with Rad52, promotes DSB repair via HR, rather than NHEJ, in order to protect cells from gene alterations. We demonstrate that Rad52 recruits BRCA1 to stimulate the removal of the RIF1-53BP1 complex-mediated obstacle for DSB end resection. Furthermore, Rad52 is recruited to the DSB site in a DNA-RNA hybrid-dependent manner and promotes XPG-mediated R-loop processing, which is the key step for the initiation of HRR. Thus, our data suggest that the actively transcribed genome is protected by a mechanism for directing DSB repair pathway toward HRR.
RESULTS

Active Transcription Directs the DSB Repair Pathway toward HRR
To clarify the roles of transcription in the repair of two-ended DSBs, we treated RPE-hTERT cells with the transcription inhibiting drug 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB) for 1 hr, which efficiently suppresses RNA synthesis ( Figure 1A) , before exposure to ionizing radiation (IR). The foci analysis in this study is constrained to G2-phase cells to strictly exclude any consequence of replication, which produces one-ended DSBs after IR. Although the expression levels of key HRR factors, including RPA, Rad51, CtIP, BRCA1, and Rad52 proteins, were unchanged by DRB treatment (Figure 1B) , the enumeration of RPA and Rad51 foci formation at varying times after IR revealed that DRB treatment significantly reduced the number of RPA and Rad51 foci ( Figures 1C, 1D , S1A, and S1B). We also examined several human cell lines and found that DRB treatment reproducibly reduced RPA foci numbers in irradiated G2 cells ( Figure 1E ). The reduction in RPA and Rad51 foci number was also observed upon treatment with other types of transcription inhibitors (TRis) ( Figures 1F and 1G ). In addition, DRB washout readily rescued the defect caused by the DRB treatment, confirming that any indirect consequence of blocking transcription has a minor impact on our analysis ( Figure S1C ). The frequency of sister chromatid exchange (SCE), which is an indicator of HRR events (Sonoda et al., 1999) , was significantly reduced by DRB treatment (Figure 1H) . These data suggest that active transcription is critical to initiate HRR in a fraction of DSBs. Furthermore, we employed a system of site-specific DSB induction at the transcriptionally active DAB1 gene by the ER-I-PpoI megaendonuclease (Berkovich et al., 2007) . RPA recruitment to chromatin at the I-PpoI restriction site in the DAB1 locus was dependent on active transcription ( Figure 1I ), supporting our notion that DSBs in transcriptionally active regions are repaired by HRR in a transcription-dependent manner. We designated this type of DSB repair by HR as TA-HRR (transcription associated homologous recombination repair) ( Figure 1J ).
Rad52 Promotes the Initiation of TA-HRR
A previous study suggested that yeast Rad52, a central player of HRR, is a mediator linking transcribed RNAs with DSB repair (Keskin et al., 2014) . Although Rad52 is a well-conserved protein from yeast to human, roles of Rad52 are not necessarily conserved (Ait Saada et al., 2017; Bhowmick et al., 2016; Hanamshet et al., 2016; Ivanov et al., 1996; Sotiriou et al., 2016) . Therefore, we created a Rad52-depleted (DRad52) RPE cell line using the CRISPR-Cas9-mediated genome editing technique (Chiang et al., 2016) ( Figure S2A ) and examined roles for human Rad52 in HRR. Interestingly, we found that DRad52 in RPE cells significantly reduced the number of RPA and Rad51 foci after IR as well as SCE events , which occurs independently of BRCA2 ( Figure S2F ), suggesting that Rad52 promotes RPA recruitment upstream of BRCA2. Importantly, TRi treatment of wild-type cells reduced the number of RPA foci, Rad51 foci, and SCE events to that observed in DRad52 cells (Figures 2D, 2E, and S2G) . Thus, these data illustrate a role for human Rad52 in the initiation of TA-HRR ( Figure 2F ). To further consolidate these findings, we utilized the genome-wide DSB induction system (Aymard et al., 2014) and compared the dependency of Rad51 recruitment in transcriptionally active versus inactive loci on Rad52. We specifically chose four genomic loci where Rad51 is preferentially recruited upon AsiSI cutting based on the previous study (Aymard et al., 2014;  Figure S2H ). Of these, CCDC47 and PIP5KL1 loci were selected as transcriptionally active and RXRA and UBE2G1 loci as transcriptionally inactive, based on the level of an identified by DAPI and nucleolin staining, respectively. The EU signal inside the nucleus, except nucleoli, was quantified using ImageJ software. Scale bars, 10 mm. Mann-Whitney test; DMSO, n = 190; DRB, n = 153; ***p < 0.001. (B) The effect of DRB treatment for 3 hr on the expression of RPA, Rad51, CtIP, BRCA1, and Rad52 proteins was analyzed by western blot. (C and D) The effect of DRB treatment on the kinetics of HRR was analyzed by measuring the number of RPA (C) and Rad51 (D) foci in G2 cells at the indicated time points after IR. CENPF positive and 5-ethynyl-2 0 -deoxyuridine (EdU) negative cells were identified as G2-phase cells. Representative images were shown. Scale bars, 10 mm. The number of RPA and Rad51 foci at the indicated time point was analyzed by boxplots and tested by the Mann-Whitney test; n = 50; ***p < 0.001. (E) The effect of DRB treatment on RPA foci formation was analyzed in the indicated cell lines. Error bars, SD. (F and G) The effect of DRB, triptolide (1 mM) or flavopiridol (0.5 mM) treatment on HRR was analyzed by measuring the number of RPA (F) and Rad51 (G) foci. Error bars, SD. (H) The number of SCEs per cell after IR was analyzed in DRB-treated cells. The workflow for this experiment and an example image for SCEs are shown. Scale bar, 10 mm. A total of 50 mitotic cells per condition from three independent preparations were scored. Error bars, SD. (I) The effect of DRB treatment on RPA recruitment to chromatin at the I-PpoI restriction site in the DAB1 locus was analyzed by chromatin immunoprecipitation (ChIP). The schematic figure shows the position of primers. GAPDH was used as a control locus without DSB induction. The RPA/IgG (normal mouse IgG) signals normalized by input sample were normalized to -4-OHT samples. Error bars, SD. (J) A schematic representation of the DSB fraction repaired by TA-HRR. See also Figure S1 . elongating form of RNA polymerase II bound to the locus (Figure 2G) . Importantly, Rad51 recruitment after DSB induction in the transcriptionally active loci was significantly dependent on Rad52, whereas that in the transcriptionally inactive loci was not (Figures 2H and S2I) . These data strongly support our notion that Rad52 is a critical factor in the initiation of TA-HRR.
TA-HRR Prevents Gene Alterations Caused by Aberrant NHEJ
The DSB repair kinetics assessed by the number of gH2AX foci was not changed by DRB treatment ( Figure 3A ), indicating that repair was switched to another pathway. To gain insight into the pathway used, we created a NHEJ-defective DLIG4 cell line ( Figure S3A ) and examined the impact of TRi treatment on DSB repair. Although DRB treatment of DLIG4 cells reduced the number of RPA foci as in wild-type cells ( Figure S3B ), the number of gH2AX foci at 2 hr after IR was significantly increased by DRB treatment in DLIG4 cells, but not in wild-type cells (Figures 3B and 3C) . These data indicate that, upon TRi treatment, the repair pathway for a fraction of DSBs is switched from HRR to NHEJ. As observed following TRi treatment, the repair pathway was switched from HRR to NHEJ after Rad52 depletion without changing the repair kinetics ( Figures 3D-3F ). Collectively, our data demonstrate that active transcription and Rad52 promote DSB repair via HR, rather than NHEJ. The above data led us to hypothesize that dysfunction of TA-HRR might increase genomic alterations by promoting irregular NHEJ execution in transcriptionally active regions. To test this hypothesis, we examined fusion events between distinct chromatids (interchromatid fusion; an expected product of misrepair by NHEJ in irradiated G2-phase cells). Strikingly, the frequency of interchromatid fusions was increased by both DRB treatment and DRad52, whereas those in DLIG4 cells were not increased by DRB treatment ( Figure 3G ), suggesting that irregular NHEJ caused by dysfunction of TA-HRR can increase genomic alterations. Furthermore, we found that CtIP knockdown (KD), which suppresses almost all HRR events (Shibata et al., 2011 ; see also Figure 4G ), does not have an additive effect on the frequency of interchromatid fusions observed in DRad52 cells ( Figure 3H ). These data strongly suggest that, of all the HRR events, TA-HRR is critically important for suppressing genomic alterations. We next referenced the Cancer Genome Atlas (TCGA) database to test whether dysfunction of TA-HRR increases genomic alterations in gene loci. We found that the breast cancer samples with low Rad52 expression had more insertions/deletions in gene loci and gene fusions than those with normal/high Rad52 expression ( Figures S3C-S3E ). These data strongly support our notion that dysfunction of TA-HRR can increase gene alterations in transcriptionally active genome.
Rad52 Recruits BRCA1 to Antagonize the RIF1-53BP1 Complex during TA-HRR While investigating factors involved in TA-HRR, we found that 53BP1 or RIF1 KD restored RPA foci number in DRad52 cells to the levels of wild-type cells ( Figures 4A and 4B ). These data suggest that the RIF1-53BP1 complex is a potential obstacle for TA-HRR. Curiously, the reduction in RPA foci in DRB-treated cells in both wild-type and DRad52 cells were not rescued by 53BP1 or RIF1 KD ( Figures 4A and 4B ). Thus, we suggest that active transcription, but not Rad52, is pre-requisite for the initiation of TA-HRR ( Figure S4A ). As Rad52 was likely to be required for removal of the RIF1-53BP1-mediated resection blockade that impedes the progression of TA-HRR, we next examined repositioning of 53BP1 (Alagoz et al., 2015; Densham et al., 2016; Isono et al., 2017; Kakarougkas et al., 2013) , which is known to arise during the progression of HRR. The number of expanded 53BP1 foci, which were mostly co-localized with Rad51, was significantly reduced in DRad52 cells ( Figures 4C and S4B ). These phenotypes of DRad52 cells were reminiscent of those in BRCA1-depleted cells ( Figures S4C and S4D ) (Zimmermann and de Lange, 2014) . Therefore, we investigated the involvement of BRCA1 in TA-HRR. BRCA1 KD reduced the RPA foci number in wild-type cells, but not in DRad52 cells ( Figure 4D ), suggesting (C) and (D) . Error bars, SD. (G) The effect of DRB treatment, DRad52, and DLIG4 on genomic alterations was analyzed by scoring interchromatid fusions after 2 Gy IR in G2 cells. Representative images are shown. Scale bar, 10 mm. A total of 150 mitotic cells per condition from three independent preparations were scored. Error bars, SD. (H) The effect of CtIP KD on genomic alterations in DRad52 was analyzed as in (G) . Error bars, SD. See also Figure S3 . that BRCA1 is also a factor involved in the initiation of TA-HRR. Dysfunction of TA-HRR caused by BRCA1 depletion, like TRi treatment or DRad52, did not confer a DSB repair defect in wild-type cells, but the defect became manifest in DLIG4 cells (Figures S4E and S4F) .
We next sought to examine BRCA1 recruitment during TA-HRR. BRCA1 is recruited to DSB sites with RAP80 as well as multiple proteins (Hu et al., 2011) . Since the BRCA1-RAP80 complex has a role to suppress HRR, we examined HRR-related BRCA1 recruitment in a DRAP80 background. Consistent with previous observations, DRAP80 cells had an increased number of RPA foci compared with wild-type cells. The formation of RPA foci, including those increased by DRAP80, was inhibited by treatment with TRi, Rad52 KD, or BRCA1 KD, suggesting that RAP80 suppresses the initiation of TA-HRR ( Figures S5A and S5B ). The 10-15 BRCA1 foci observed at 30 min post 2 Gy IR in G2 DRAP80 cells ( Figure S5C ) were significantly abolished by DRB treatment ( Figure 4E , left), suggesting that these BRCA1 foci represent TA-HRR-related BRCA1 recruitment. Intriguingly, BRCA1 recruitment during TA-HRR was dependent on Rad52 (Figure 4E, right) , indicating that Rad52 recruits BRCA1 to initiate TA-HRR.
Previous studies demonstrated that ATM kinase activity and CtIP and MRE11 endonuclease activity cooperatively initiate DSB end resection (Shibata et al., 2014) . Therefore, we next sought to determine the roles of these factors in TA-HRR. We found that ATM kinase activity is extensively required for the initiation of HRR, including TA-HRR ( Figure 4F ). To define the roles of ATM in TA-HRR, we first tested the RNF8-and RNF168-dependent ubiquitin signaling cascade activated by the ATM kinase upon DSB induction (Jackson and Durocher, 2013; Messick and Greenberg, 2009 ). We found that neither RNF8 nor RNF168 KD affects the RPA recruitment after IR, suggesting that ATM-mediated activation of the ubiquitin signaling cascade is not required for the initiation of HRR ( Figure S5D ). We next examined the roles of ATM-mediated phosphorylation of BRCA1 and CtIP. Serine to alanine mutation of three ATM phosphorylation sites in BRCA1 (S1387A/S1423A/S1524A) failed to rescue the reduction in RPA foci corresponding to TA-HRR in BRCA1 KD cells ( Figures 4D and S5E ). Moreover, serine to alanine mutation of ATM phosphorylation sites in CtIP (S664A/S745A and S664A/S679A/S745A) failed to rescue the loss of RPA foci in CtIP KD cells (Figures 4G and S5F) . These data indicate the critical roles of ATM in TA-HRR; ATM-mediated phosphorylation of BRCA1 and CtIP is required to initiate TA-HRR. In contrast, we found that the C61 residue in BRCA1, which is critical for BRCA1 E3 ligase activity, is dispensable for TA-HRR (Figure S5E) . Interestingly, Rad52 sumoylation, a modification important for Rad52 function in DSB repair in yeast (Torres-Rosell et al., 2007) , was dependent on the ATM kinase activity ( Figure S5G ). However, the lysine to arginine mutation of sumoylated sites in human Rad52 (K412R/K414R) (Saito et al., 2010) could rescue the RPA foci corresponding to TA-HRR in DRad52 cells ( Figures  S5H and S5I ), suggesting that ATM-mediated sumoylation of Rad52 is not required for the initiation of TA-HRR.
Moreover, the S327 residue in CtIP and the S1655 residue in the BRCT domain of BRCA1, both of which are required for BRCA1-CtIP interaction, are indispensable for the initiation of TA-HRR ( Figures 4H and S5E ). Taken together with the finding that BRCA1 recruitment during TA-HRR is dependent on CtIP ( Figure 4I ), these data suggest that the interaction between BRCA1 and CtIP is critical for TA-HRR. In contrast, MRE11 nuclease was dispensable for RPA recruitment during TA-HRR ( Figures S5J and S5K ), although this does not rule out a distinct downstream role of MRE11 in TA-HRR. We, therefore, suggest that ATM-mediated phosphorylation of the BRCA1-CtIP complex plays a critical role in the initiation of TA-HRR ( Figure S5L ).
DNA-RNA Hybrid-Dependent Recruitment of Rad52
Initiates TA-HRR Next, we examined Rad52 recruitment to DNA lesions induced by near infrared (730 nm) two-photon microbeam irradiation, which, of the laser-type systems frequently employed, induces mostly IR-like DNA lesions with minimum UV photoproducts, such as CPD/6-4PP (Reynolds et al., 2013) . Indeed, XPF, a critical nucleotide excision repair (NER) factor recruited upon UV photoproduct induction, was not recruited at laser tracks in this system (see Figure S7E ). Upon laser irradiation of U2OS DRad52 S/G2 cells transfected with GFP-tagged Rad52, we found that Rad52 is recruited within 60 s after laser irradiation independently of ATM kinase activity, and this was significantly suppressed by DRB treatment (Figures 5A and S6A ). Previous studies have demonstrated that Rad52 promotes DNA-RNA hybrid formation in vitro, and this activity is critical for the DSB repair functions of Rad52 in yeast (Keskin et al., 2014) . However, immunofluorescence analysis of laser tracks using the DNA-RNA hybrid-specific antibody did not reveal any dependency of DNA-RNA hybrid formation on Rad52 in human cells ( Figure 5B ). These data strongly suggest that Rad52 does not contribute to DNA-RNA hybrid formation upon laser-induced DNA damage. To examine the kinetics of DNA-RNA hybrid formation after DNA damage, we employed a previously reported indicator, which allows them to be tracked in real time (Bhatia et al., 2014 ) ( Figure S6B ). Consistent with the immunofluorescence data above, the GFP-tagged hybrid-binding domain of RNase H1 (GFP-HB) accumulated at the laser tracks within 60 s after irradiation in a transcriptiondependent, but Rad52-independent, manner ( Figure 5C ). These data raised the alternative possibility that Rad52 recruitment might be dependent on DNA-RNA hybrid formation after DNA damage. Indeed, in cells overexpressing the nuclear-localized RNaseH1, where DNA-RNA hybrids were continuously resolved ( Figure S6C ), Rad52 recruitment to the laser tracks was significantly attenuated ( Figure 5D ). Thus, these data suggest that DNA-RNA hybrids formed upon DNA damage are required for Rad52 accumulation. Consistent with the finding above that BRCA1 recruitment is dependent on Rad52 ( Figure 4E ), BRCA1 foci formation after IR was also attenuated by RNaseH1 overexpression in DRAP80 cells ( Figure 5E ). Moreover, the number of RPA foci after IR was reduced in RNaseH1-overexpressed wild-type cells but not in RNaseH1-overexpressed DRad52 cells, while the number of gH2AX foci was unchanged ( Figures 5F and  S6D) . Collectively, our data clearly demonstrate that DNA-RNA hybrids formed upon DSB induction in a transcription-dependent manner promote the initiation of TA-HRR by recruiting Rad52 and BRCA1. Importantly, DNA-RNA hybrids were dispensable for TA-HRR in a D53BP1 condition ( Figure S6E ). Taken together with the data that DNA-RNA hybrids are required for recruitment of Rad52 and BRCA1 ( Figures 5D and 5E ), these data suggest that DNA-RNA hybrids formed upon DSB induction play a critical role in initiating BRCA1-mediated antagonization of the RIF1-53BP1 blockade.
Rad52 Promotes XPG-Mediated R-loop Processing to Initiate TA-HRR We next asked whether R-loop resolution is critical to initiate TA-HRR as shown in yeast (Ohle et al., 2016) . We found that the clearance of DNA-RNA hybrids was retarded in DRad52 cells compared to wild-type cells ( Figure 6A ), suggesting that R-loops formed upon DNA damage are processed in a Rad52-dependent manner. In contrast, KD of RNaseH1, SETX, or AQR had minor impact on the kinetics of GFP-HB accumulation/clearance and RPA foci formation during TA-HRR ( Figures 6A and S7A ). Furthermore, BRCA1 KD, CtIP KD, and treatment with the ATM inhibitor had no significant effect on the kinetics of GFP-HB accumulation/clearance ( Figures 6A and S7B) . To consolidate the Rad52 involvement in DNA-RNA hybrid resolution upon DSB induction, we performed DNA-RNA immunoprecipitation (DRIP) assay using the ER-I-PpoI cells. DNA-RNA hybrids formed upon DSB induction were significantly increased in Rad52 KD cells ( Figures 6B and S7C) . These data strongly support our findings that Rad52 promotes resolution of DNA-RNA hybrids formed upon DSB induction.
A previous study has suggested that NER factors are involved in the processing of R-loops accumulated following AQR or SETX KD (Sollier et al., 2014) . We therefore tested the two endonucleases XPG and XPF, which function during NER to remove damaged nucleotides by incising the dsDNA-ssDNA junctions. Intriguingly, the endonuclease activity of XPG, but not XPF, was required for Rad52-dependent R-loop processing ( Figures  6C-6E ). Consistent with these data, the DRIP assay revealed that DNA-RNA hybrids formed upon DSB induction were significantly increased in XPG KD cells ( Figure 6F ). We further showed that DRad52 significantly attenuated the accumulation of XPG to the laser tracks, whereas XPG KD had no significant effect on the accumulation of Rad52 (Figures 6G and S7D) . Importantly, XPF accumulation was not observed within the time window of our analysis ( Figure S7E ), suggesting that XPG accumulation observed in Figure 6G is likely to be distinct to that observed during NER. In addition, ATM kinase activity was dispensable for XPG accumulation ( Figure S7F ). Thus, our data suggest that a proportion of R-loops formed after DNA damage is processed by Rad52 and XPG within $2 min after laser irradiation ( Figure S7G ).
Finally, we asked whether the Rad52-XPG axis-mediated Rloop processing is responsible for DSB repair by TA-HRR after IR. RPA foci formation analysis revealed that XPG is another critical factor in the initiation of TA-HRR by counteracting 53BP1 but is dispensable following D53BP1 (Figures 6H-6J ). Thus, our data strongly suggest that XPG-mediated R-loop processing is required for the initiation of TA-HRR ( Figure 6K ). Overall, our data reveal a cooperative mechanism between Rad52, XPG, and BRCA1 during the initiation of TA-HRR (Figure 7 ; see Discussion).
DISCUSSION
The Roles of Rad52 and XPG in R-loop Processing for HRR In this study, we have successfully tracked formation and resolution of DNA-RNA hybrids after DSB induction in a real-time manner using the GFP-HB indicator (Bhatia et al., 2014) . The results from these experiments have provided important insight into how R-loops contribute to DSB repair in human cells. According to our analysis, a requisite for accumulation of DNA-RNA hybrids is ongoing transcription ( Figure 5C ). Given that the genomic regions where RNA polymerase II frequently pauses are susceptible to DNA-RNA hybrid formation (Aguilera and García-Muse, 2012), unscheduled pausing of ongoing transcription upon DSB induction would be a trigger for DNA-RNA hybrid formation. Therefore, transcribed genes would be highly susceptible to DNA-RNA hybrid formation upon DSB induction. Indeed, recent studies have reported that DNA-RNA (legend on next page) hybrids form in the proximity of DSBs at transcriptionally active genomic regions (Cohen et al., 2018; Lu et al., 2018) . They also showed that Drosha-dependent DNA-RNA hybrid formation and SETX-mediated DNA-RNA hybrid resolution promote Rad51 recruitment without affecting DSB end resection, suggesting that DNA-RNA hybrids are required to promote HRR downstream of resection at these DSBs. In contrast and consistent with findings in a previous study in yeast (Ohle et al., 2016) , we identified a subset of DSBs in human cells that require DNA-RNA hybrids for RPA recruitment and subsequent HRR. Therefore, our data suggest that R-loops serve as a signal for executing HRR in this fraction of DSBs ( Figure 5F ). Thus, TA-HRR, in which R-loops serve as a key structure to promote the process, represents a mechanism by which DSBs within transcriptionally active regions favor accurate repair via HRR. Importantly, we found that Rad52 is recruited to laser tracks in a DNA-RNA hybrid-dependent manner to transduce the R-loop-mediated signal for executing HRR ( Figure 5D ). This function of Rad52 is supported by its in vitro activity for binding to DNA-RNA hybrids, rather than forming DNA-RNA hybrids (Mazina et al., 2017) . Importantly, our data reveal a role for the NER factor XPG in the initiation of TA-HRR ( Figures 6C-6K) . In contrast to the previous findings of the non-catalytic roles of XPG in HRR (Trego et al., 2016) , our data strongly suggest that XPG incises R-loops formed upon DNA damage by its endonuclease activity ( Figure 6D ). XPG has a structure-specific ssDNA endonuclease activity to incise at the 3 0 junction of DNA loop structures (O'Donovan et al., 1994) . Given that a 3 0 overhang is required for the initiation of HRR, the position of XPG incision in R-loop structures would be the template strand of transcription when transcription is in a direction to collide with the DSB (Figure 7) or the non-template strand when transcription is in a direction to leave from the DSB ( Figure S7H) . In contrast to the evidence in yeast that RNaseH is responsible for the resolution of R-loops after DSB induction (Ohle et al., 2016) , our data in human cells demonstrate that Rad52 and XPG cooperate to process R-loops after DSB induction. Therefore, although R-loops positively impact on HRR in both yeast and human, the mechanism by which cells deal with and utilize R-loops during HRR might be distinct between organisms.
R-loops Originated from Ongoing Transcription Trigger DSB Repair via HR
Accumulated evidence proposes the notion that DSBs in transcriptionally active regions are accurately repaired by HRR (Aymard et al., 2014) . Throughout this study, we consistently detected that 5-10 DSBs ($5% of total DSBs after 2 Gy IR in G2 cells) are repaired by TA-HRR. This was increased to 10-15 under the DRAP80 condition, suggesting that the potential frequency of TA-HRR is approximately 10% of the total DSBs induced. According to findings from the ENCODE project, a comprehensive analysis of the human genome, over 60% of the human genome has the potential to be transcribed (Djebali et al., 2012) . Although protein coding genes cover 2.94% of the whole genome, the proportion of open chromatin is estimated as 15.2%, and either transcription factors or DNase I footprints occupy 8.5% of the genome according to the most conservative estimation (Djebali et al., 2012) . Thus, a potential frequency of encounters between ongoing transcription and DSBs at around 10% of the randomly induced DSBs appears reasonable.
Although TRis have pleiotropic effects on cellular functions, we confirmed that (1) DRB treatment in the time window of our analysis does not change the expression levels of HR-related proteins ( Figure 1B) , (2) three independent inhibitors, including at least two independent modes of action, gave the same phenotypes ( Figures  1F and 1G) , and (3) DRB washout completely rescues the defect caused by the DRB treatment ( Figure S1C ). These data suggest that the indirect consequence of blocking transcription has a minor effect on RPA foci formation after IR. Recently, it has been shown that DSB-induced RNAs (diRNAs) transcribed upon DSB induction are involved in regulation of the DNA damage response (DDR) (D'Alessandro and d'Adda di Fagagna, 2017) . However, diRNAs contribute to DDR without forming DNA-RNA hybrids (Michelini et al., 2017) . In addition, we show that TA-HRR is inhibited by treatment with triptolide, which is unlikely to interfere with diRNA transcription because it specifically suppresses promoter-dependent initiation of transcription (Titov et al., 2011) (Figures 1F, 1G, 2D, and 2E) . Collectively, these data strongly suggest that R-loops utilized during TA-HRR are derived from ongoing transcription, rather than de novo transcription. 
TA-HRR Is the Mechanism for Protection of the Actively Transcribed Genome
Given that altered genomic sequences exert their deleterious effects only following transcription, it is reasonable that cells employ the most precise repair pathway, namely, HR for repair of DSBs arising in transcriptionally active regions. Consistent with this notion, our chromosome analysis in irradiated G2 cells revealed that dysfunction of TA-HRR increases genomic aberrations ( Figures 3G and 3H ). Since some types of interchromatid fusions do not impede cell division, these fusions can be carried over to the next cell cycle as persistent chromosomal translocations (Nussenzweig and Nussenzweig, 2010) . Therefore, our data suggest that Rad52-dependent TA-HRR prevents genomic alterations in transcriptionally active regions. This notion was also strongly supported by our database analysis that low Rad52 expression in cancer samples is associated with a greater increase in genomic alterations in gene loci ( Figure S3D ). Importantly, although over 70% of DSB repair after IR via NHEJ rarely produces genomic aberrations, the repair pathway switch from TA-HRR to NHEJ at only 5% of total DSBs strikingly increased genomic aberrations ( Figure 3G ). Furthermore, specific inhibition of TA-HRR by Rad52 depletion results in a comparable increase in genomic alterations to that observed following inhibition of all HRR events by CtIP KD (Figure 3H ), highlighting the extreme importance of the TA-HRR mechanism in the maintenance of genome stability. Therefore, we propose that TA-HRR is the mechanism for suppression of gene alterations in transcriptionally active regions, the dysfunction of which contributes to the oncogenic process.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
ACKNOWLEDGMENTS
We greatly appreciate critical discussion with Prof. Penny A. Jeggo. We thank Dr. Ryo Sakasai and Dr. Ryotaro Nishi for helpful discussions. The All-in-One CRISPR-Cas9D10A nickase vector is a generous gift from Prof. Steve Jackson. The U2OS AsiSI cell line was a generous gift from Dr. Gaë lle Legube. The HT1080 ER-I-PpoI cell line was a generous gift from Dr. Yasuyoshi Oka. The MRE11 inhibitors are generous gifts from Dr. Elena Petricci. This work was carried out under the support of Isotope Science Center, The University of Tokyo. This work utilized the core research facility of Center for Biology and Integrative Medicine, The University of Tokyo, which were organized by The University of Tokyo Center for NanoBio Integration entrusted by Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan. This work was supported by JSPS KAKENHI grants JP15H06146 and JP18K18191 to T.Y., JP15H04902 and JP15K14376 to K.M., and JP26701005 and JP17H04713 to A.S.
AUTHOR CONTRIBUTIONS
T.Y. primarily conceived and designed the study discussing with A.S. R.K. and T.Y. performed most of the experiments. Y.H. blindly evaluated the slides for Figure 7 . The Model for the Initiation Mechanism of TA-HRR A schematic model for transcriptionally active genome protection by TA-HRR, which occurs in $5% of total DSBs. DNA-RNA hybrids formed upon DSB induction recruit Rad52, XPG, and BRCA1. R-loops are processed by the endonuclease activity of XPG and the RIF1-53BP1 complex is antagonized by BRCA1, both of which are required for the initiation of extensive end resection, followed by RPA and Rad51 recruitment. ATM-mediated phosphorylation of CtIP and BRCA1 is also required for the initiation of TA-HRR. The model when transcription is in a direction to collide with the DSB is shown. For the model when transcription is in a direction to leave from the DSB, see Figure S7H . RNA, red line; DNA, blue line. Oligonucleotides siRNA sequence, see Table S1 This study N/A Primers for cloning, see Table S2 This study N/A Primers for ChIP, see Table S2 This study N/A Primers for CRISPR, see 
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Cell Lines All cell lines were cultured in a 37 C incubator at 5% CO 2 . The RPE cell line was cultured in DMEM/F-12 medium. The U2OS cell line was cultured in McCoy's 5A medium. The U2OS AsiSI cell line was cultured in MEM medium. The 1BR-hTERT cell line and HT1080 ER-I-PpoI cell line (Oka et al., 2011) were cultured in a-MEM medium. The other cell lines were cultured in DMEM medium. All media were supplemented with 10% or 20% fetal bovine serum and penicillin/streptomycin. For ionizing irradiation, a Pantak HF 350 (Shimadzu) or a CellRad (Faxitron) was used at a dose rate of 1.3-2 Gy s À1 .
METHOD DETAILS
Creation of Cell Lines
The target genes were depleted from RPE or U2OS cells using the All-in-One CRISPR-Cas9 D10A nickase-based system as described previously (Chiang et al., 2016) . Essentially, All-in-One CRISPR-Cas9D10A vector (Addgene plasmid # 74119) including the gRNAs specific for each target gene and the GFP-labeled Cas9 D10A nickase was transfected, and transfected-cells were enriched by fluorescent-based sorting using a FACSAria II cell sorter (Becton Dickinson) and seeded in 96-well plates. After PCR-based screening, depletion of the target protein expression was confirmed by western blot (Yasuhara et al., 2014) .
Immunofluorescence
For foci analysis in irradiated G2 cells, cells grown on a coverslip were treated with 5-ethynyl-2 0 -deoxyuridine (EdU; 10 mM) for 1-1.5 h, TRi for 1 h and ATMi (10 mM) or MRE11i (100 mM) for 30 m before IR and subsequent fixation at the indicated time point. For staining of RPA foci, cells were pre-extracted 2 times with the CSK-R buffer (Britton et al., 2013) for 3 m before fixation with the 2% paraformaldehyde (PFA) in CSK buffer for 10 m. For BRCA1 foci, cells were pre-extracted with the CSK buffer for 5 m before fixation with 4% PFA in PBS. For other foci, cells were fixed with 4% PFA in PBS without pre-extraction. For the EU incorporation assay, cells treated with DMSO or DRB for 1 h were incubated in the presence of EU (1 mM) for 30 m, followed by fixation with 4% PFA. Fixed cells were permeable with 0.1% SDS, 0.5% Triton-X in PBS for 5 m and incubated with primary antibodies for 1 h at 37 C. After incubation with secondary antibodies, incorporated EdU or EU was visualized by a click chemistry procedure before cells were counterstained with 4',6-diamidino-2-phenylindole (DAPI) and mounted in the VECTASHIELD mounting medium (VECTOR Laboratories, Inc). For immunofluorescence by the S9.6 antibody, cells were fixed with 100% methanol for 5 m at À20 C and incubated with the primary antibodies overnight at 4 C. For identification of irradiated G2-phase cells, we utilized the positive CENPF staining and negative EdU signal. Images were captured using a BX51 fluorescence microscope (Olympus), a CS-60M digital camera (BITRAN) or a LSM 510 META (Zeiss).
SCE and Chromosome Analysis
For analysis of SCEs, cells were plated in medium supplemented with 10 mM BrdU and incubated for 40 h before irradiation. Irradiated cells were treated with 300 nM UCN-01 and 0.1 mg mL À1 Colcemid for 3 h to collect mitotic cells after 9 h incubation for repair in the presence of aphidicolin (APH; 4 mM). Detached cells were swelled with pre-warmed 75 mM KCl at 37 C, followed by fixation with methanol:acetic acid (3:1). Chromosome spreads were left for 1-3 d to dry. The slides were stained with 0.1 mg mL À1 acridine orange for 10 m at room temperature and mounted in McIlvaine buffer after washing with water. For interchromatid fusion analysis, the slides were prepared as described above except BrdU addition, and finally stained with 1 mg mL À1 DAPI.
ChIP Assay
The HT1080 ER-I-PpoI or U2OS AsiSI cell line was treated with 4-Hydroxytamoxifen (4-OHT; 0.3-2.5 mM depending on the assay) to induce site specific DSBs, and fixed using 1% PFA for 10 m at room temperature. After quenching by 0.125 M glycine, cells were lysed on ice in ChIP lysis buffer (50 mM Tris-HCl pH 8.0, 140 mM NaCl, 1 mM EDTA pH 8.0, 1% Triton X-100, 0.1% sodium deoxycholate, and 0.1% sodium dodecyl sulfate (SDS), supplemented with 1mM dithiothreitol, 1mM phenylmethylsulphonyl fluoride, 10 mg mL À1 aprotinin, 50 nM cantharidin and 5 nM Microcystin-LR). The lysate was then sonicated and cleared by centrifugation. The lysate was immunoprecipitated and washed three times with ChIP wash buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA pH 8.0, 1% Triton X-100, and 0.1% SDS) and once with ChIP final wash buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 2 mM EDTA pH 8.0, 1% Triton X-100, and 0.1% SDS). The immunoprecipitate was eluted at room temperature for 15 m using ChIP elution buffer (1% SDS and 100 mM NaHCO 3 ). After the addition of 0.5 mg mL À1 RNase A and 0.1 mg mL À1 Proteinase K, the eluate was incubated at 65 C overnight to reverse the crosslinks. DNA was purified with Illustra GFX PCR DNA and Gel Band Purification Kits (GE Healthcare) according to the manufacturer's instructions. The primers used in the ChIP assays are shown in Table S2 . Quantitative PCR was performed using a 7500FAST instrument (Applied Biosystems) according to the manufacturer's instructions.
DRIP Assay
The ER-I-PpoI cell line was treated with 4-OHT (300 nM) for 1 h, and the total nucleic acids were prepared using DNeasy Blood & Tissue Kits (QIAGEN) according to the manufacturer's instructions. DNA-RNA hybrids were immunoprecipitated from 2 mg of the total nucleic acids using S9.6 antibody (1 mg) overnight. The immunoprecipitate was purified and analyzed as ChIP samples.
siRNAs and Nucleotides
The siRNAs used in this study are listed in Table S1 . The oligonucleotides are listed in Table S2 . Cells were transfected with the indicated siRNAs using DharmaFECT (GE healthcare) or plasmids using ViaFect (Promega) according to the manufacturer's instructions.
Cell Cycle Analysis
Adherent U2OS AsiSI cells were harvested by shake-off in 1 mM EDTA/PBS without trypsinization. Following PBS wash, cells were suspended with propidium iodide (PI) staining solution (0.25 mg/mL PI, 0.1 mg/mL RNaseA, and 0.02% Triton-X in 1 mM EDTA/PBS). Flow cytometry analysis was performed on an Attune NxT Flow Cytometer (Thermo Fisher Scientific).
Statistics
Unless otherwise stated, bar graphs are shown as the mean ± SD (n = 50) of one experiment from at least three biological replicates and significance levels of the two-tailed Welch's t test are shown as follows; NS, not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001. The biological replicates were prepared from at least two experimenters, and all preparations were independently scored by two to three experimenters from different laboratories.
Laser Track Analysis
One day before analysis, the U2OS mCherry-Geminin wild-type or DRad52 cells plated on a 35 mm glass bottom dish (Matsunami) were transfected with the indicated plasmids using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Before laser irradiation, cells were incubated with 10 mg mL À1 Hoechst33342 (Wako) for 10 m. Cells were maintained at 37 C throughout the analysis using a temperature control chamber (Zeiss). The MaiTai laser (Spectra-Physics) was set to a wavelength of 730 nm and a nominal power of approximately 10 mW. The GFP-and mCherry-positive cells were irradiated at the track with approximately 500 nm in width using a LSM510 microscope equipped with a 3 63, NA 1.4, oil objective (Zeiss). Unless otherwise stated, images were collected at a 5 s or 10 s interval from 15-20 cells per condition from three biological replicates.
DATA AND SOFTWARE AVAILABILITY
The normalized RNA-sequence data and the gene alterations, including insertions or deletions in genes, provided by TCGA project were downloaded from the Genomic Data Commons Data Portal. The gene fusion data for each sample were obtained from TCGA Fusion gene Data Portal (Yoshihara et al., 2015) . The criteria for low Rad52 expression was set to less than the mean of the average expression of normal samples and the minimum expression among tumor samples. The proteome data were obtained from the Clinical Proteomic Technology Assessment for Cancer database (CPTAC). 
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